Feng‐Ming Tien
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 19
- Acute Myeloid Leukemia Research 16
- Multiple Myeloma Research and Treatments 3
- Chronic Myeloid Leukemia Treatments 2
- Genetics 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Hwei‐Fang Tien (20 shared papers)Jih‐Luh Tang (15 shared papers)Ming Yao (15 shared papers)Wen‐Chien Chou (19 shared papers)Chien‐Yuan Chen (7 shared papers)Hsin‐An Hou (19 shared papers)Chien‐Chin Lin (18 shared papers)Wang‐Huei Sheng (4 shared papers)
- Journals
- Blood Cancer Journal (5 papers)Hematological Oncology (2 papers)Annals of Hematology (2 papers)Nutrients (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- TaiwanUnited StatesCzechia
In The Last Decade
Feng‐Ming Tien
25 papers receiving 373 citations
Peers
Comparison fields: 5 of 46
- Hematology 194
- Genetics 74
- Cancer Research 33
- Emergency Medicine 19
- Oncology 57
Countries citing papers authored by Feng‐Ming Tien
This map shows the geographic impact of Feng‐Ming Tien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Ming Tien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Ming Tien more than expected).
Fields of papers citing papers by Feng‐Ming Tien
This network shows the impact of papers produced by Feng‐Ming Tien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Ming Tien. The network helps show where Feng‐Ming Tien may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Ming Tien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 55 | |
| 2 | 2021 | 40 | |
| 3 | 2017 | 39 | |
| 4 | 2018 | 31 | |
| 5 | 2023 | 29 | |
| 6 | 2018 | 25 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 19 | |
| 9 | 2021 | 17 | |
| 10 | 2018 | 16 | |
| 11 | 2019 | 16 | |
| 12 | 2023 | 13 | |
| 13 | 2021 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2023 | 6 | |
| 17 | 2021 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2024 | 2 |
About Feng‐Ming Tien
Feng‐Ming Tien is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 30 papers that have together received 377 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (194 citations), Genetics (74 citations), Cancer Research (33 citations), Emergency Medicine (19 citations) and Oncology (57 citations). Feng‐Ming Tien has collaborated with scholars based in Taiwan, United States and Czechia. Frequent co-authors include Hwei‐Fang Tien, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Chien‐Yuan Chen, Hsin‐An Hou, Chien‐Chin Lin, Wang‐Huei Sheng, Shang‐Yi Huang and Cheng‐Hong Tsai. Their work appears in journals such as Blood Cancer Journal, Hematological Oncology, Annals of Hematology, Nutrients and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.